1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Clinical Area Procurement Analysis
4.3.2. Sales and End User Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. AI in Medical Imaging Market, by Clinical Area
7.1.1. Lung / Pulmonology
7.1.1.1. Market Revenue and Forecast
7.1.2. Brain / Neurology
7.1.2.1. Market Revenue and Forecast
7.1.3. Heart / Cardiology
7.1.3.1. Market Revenue and Forecast
7.1.4. Oncology
7.1.4.1. Market Revenue and Forecast
7.1.5. Musculoskeletal
7.1.5.1. Market Revenue and Forecast
7.1.6. Gastroenterology / Hepatology
7.1.6.1. Market Revenue and Forecast
7.1.7. Ophthalmology
7.1.7.1. Market Revenue and Forecast
7.1.8. Other Specialties
7.1.8.1. Market Revenue and Forecast
8.1. AI in Medical Imaging Market, by Technology Type
8.1.1. Machine Learning
8.1.1.1. Market Revenue and Forecast
8.1.2. Deep Learning
8.1.2.1. Market Revenue and Forecast
8.1.3. Natural Language Processing
8.1.3.1. Market Revenue and Forecast
8.1.4. Hybrid / Multimodal AI
8.1.4.1. Market Revenue and Forecast
8.1.5. Explainable AI
8.1.5.1. Market Revenue and Forecast
9.1. AI in Medical Imaging Market, by Deployment Type
9.1.1. On-Premise
9.1.1.1. Market Revenue and Forecast
9.1.2. Cloud-Based
9.1.2.1. Market Revenue and Forecast
9.1.3. Hybrid
9.1.3.1. Market Revenue and Forecast
9.1.4. Edge / Embedded
9.1.4.1. Market Revenue and Forecast
10.1. AI in Medical Imaging Market, by Imaging Modality
10.1.1. X-ray
10.1.1.1. Market Revenue and Forecast
10.1.2. CT
10.1.2.1. Market Revenue and Forecast
10.1.3. MRI
10.1.3.1. Market Revenue and Forecast
10.1.4. Ultrasound
10.1.4.1. Market Revenue and Forecast
10.1.5. PET / SPECT
10.1.5.1. Market Revenue and Forecast
10.1.6. Other Imaging Modalities
10.1.6.1. Market Revenue and Forecast
11.1. AI in Medical Imaging Market, by Functionality
11.1.1. Image Acquisition & Reconstruction
11.1.1.1. Market Revenue and Forecast
11.1.2. Image Enhancement & Processing
11.1.2.1. Market Revenue and Forecast
11.1.3. Image Analysis
11.1.3.1. Market Revenue and Forecast
11.1.4. Workflow & Reporting
11.1.4.1. Market Revenue and Forecast
11.1.5. Predictive & Prognostic Analytics
11.1.5.1. Market Revenue and Forecast
12.1. AI in Medical Imaging Market, by Product Type
12.1.1. Software
12.1.1.1. Market Revenue and Forecast
12.1.2. AI-Enabled Hardware
12.1.2.1. Market Revenue and Forecast
13.1. AI in Medical Imaging Market, by End User
13.1.1. Hospitals
13.1.1.1. Market Revenue and Forecast
13.1.2. Diagnostic Imaging Centers
13.1.2.1. Market Revenue and Forecast
13.1.3. Research & Academic Institutes
13.1.3.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Clinical Area
14.1.2. Market Revenue and Forecast, by Technology Type
14.1.3. Market Revenue and Forecast, by Deployment Type
14.1.4. Market Revenue and Forecast, by Imaging Modality
14.1.5. Market Revenue and Forecast, by Functionality
14.1.6. Market Revenue and Forecast, by End User
14.1.7. Market Revenue and Forecast, by Product Type
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Clinical Area
14.1.8.2. Market Revenue and Forecast, by Technology Type
14.1.8.3. Market Revenue and Forecast, by Deployment Type
14.1.8.4. Market Revenue and Forecast, by Imaging Modality
14.1.8.5. Market Revenue and Forecast, by Functionality
14.1.8.6. Market Revenue and Forecast, by End User
14.1.8.7. Market Revenue and Forecast, by Product Type
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Clinical Area
14.1.9.2. Market Revenue and Forecast, by Technology Type
14.1.9.3. Market Revenue and Forecast, by Deployment Type
14.1.9.4. Market Revenue and Forecast, by Imaging Modality
14.1.9.5. Market Revenue and Forecast, by Functionality
14.1.9.6. Market Revenue and Forecast, by End User
14.1.9.7. Market Revenue and Forecast, by Product Type
14.2. Europe
14.2.1. Market Revenue and Forecast, by Clinical Area
14.2.2. Market Revenue and Forecast, by Technology Type
14.2.3. Market Revenue and Forecast, by Deployment Type
14.2.4. Market Revenue and Forecast, by Imaging Modality
14.2.5. Market Revenue and Forecast, by Functionality
14.2.6. Market Revenue and Forecast, by End User
14.2.7. Market Revenue and Forecast, by Product Type
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Clinical Area
14.2.8.2. Market Revenue and Forecast, by Technology Type
14.2.8.3. Market Revenue and Forecast, by Deployment Type
14.2.8.4. Market Revenue and Forecast, by Imaging Modality
14.2.8.5. Market Revenue and Forecast, by Functionality
14.2.8.6. Market Revenue and Forecast, by End User
14.2.8.7. Market Revenue and Forecast, by Product Type
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Clinical Area
14.2.9.2. Market Revenue and Forecast, by Technology Type
14.2.9.3. Market Revenue and Forecast, by Deployment Type
14.2.9.4. Market Revenue and Forecast, by Imaging Modality
14.2.9.5. Market Revenue and Forecast, by Functionality
14.2.9.6. Market Revenue and Forecast, by End User
14.2.9.7. Market Revenue and Forecast, by Product Type
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Clinical Area
14.2.10.2. Market Revenue and Forecast, by Technology Type
14.2.10.3. Market Revenue and Forecast, by Deployment Type
14.2.10.4. Market Revenue and Forecast, by Imaging Modality
14.2.10.5. Market Revenue and Forecast, by Functionality
14.2.10.6. Market Revenue and Forecast, by End User
14.2.10.7. Market Revenue and Forecast, by Product Type
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Clinical Area
14.2.11.2. Market Revenue and Forecast, by Technology Type
14.2.11.3. Market Revenue and Forecast, by Deployment Type
14.2.11.4. Market Revenue and Forecast, by Imaging Modality
14.2.11.5. Market Revenue and Forecast, by Functionality
14.2.11.6. Market Revenue and Forecast, by End User
14.2.11.7. Market Revenue and Forecast, by Product Type
14.3. APAC
14.3.1. Market Revenue and Forecast, by Clinical Area
14.3.2. Market Revenue and Forecast, by Technology Type
14.3.3. Market Revenue and Forecast, by Deployment Type
14.3.4. Market Revenue and Forecast, by Imaging Modality
14.3.5. Market Revenue and Forecast, by Functionality
14.3.6. Market Revenue and Forecast, by End User
14.3.7. Market Revenue and Forecast, by Product Type
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Clinical Area
14.3.8.2. Market Revenue and Forecast, by Technology Type
14.3.8.3. Market Revenue and Forecast, by Deployment Type
14.3.8.4. Market Revenue and Forecast, by Imaging Modality
14.3.8.5. Market Revenue and Forecast, by Functionality
14.3.8.6. Market Revenue and Forecast, by End User
14.3.8.7. Market Revenue and Forecast, by Product Type
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Clinical Area
14.3.9.2. Market Revenue and Forecast, by Technology Type
14.3.9.3. Market Revenue and Forecast, by Deployment Type
14.3.9.4. Market Revenue and Forecast, by Imaging Modality
14.3.9.5. Market Revenue and Forecast, by Functionality
14.3.9.6. Market Revenue and Forecast, by End User
14.3.9.7. Market Revenue and Forecast, by Product Type
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Clinical Area
14.3.10.2. Market Revenue and Forecast, by Technology Type
14.3.10.3. Market Revenue and Forecast, by Deployment Type
14.3.10.4. Market Revenue and Forecast, by Imaging Modality
14.3.10.5. Market Revenue and Forecast, by Functionality
14.3.10.6. Market Revenue and Forecast, by End User
14.3.10.7. Market Revenue and Forecast, by Product Type
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Clinical Area
14.3.11.2. Market Revenue and Forecast, by Technology Type
14.3.11.3. Market Revenue and Forecast, by Deployment Type
14.3.11.4. Market Revenue and Forecast, by Imaging Modality
14.3.11.5. Market Revenue and Forecast, by Functionality
14.3.11.6. Market Revenue and Forecast, by End User
14.3.11.7. Market Revenue and Forecast, by Product Type
14.4. MEA
14.4.1. Market Revenue and Forecast, by Clinical Area
14.4.2. Market Revenue and Forecast, by Technology Type
14.4.3. Market Revenue and Forecast, by Deployment Type
14.4.4. Market Revenue and Forecast, by Imaging Modality
14.4.5. Market Revenue and Forecast, by Functionality
14.4.6. Market Revenue and Forecast, by End User
14.4.7. Market Revenue and Forecast, by Product Type
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Clinical Area
14.4.8.2. Market Revenue and Forecast, by Technology Type
14.4.8.3. Market Revenue and Forecast, by Deployment Type
14.4.8.4. Market Revenue and Forecast, by Imaging Modality
14.4.8.5. Market Revenue and Forecast, by Functionality
14.4.8.6. Market Revenue and Forecast, by End User
14.4.8.7. Market Revenue and Forecast, by Product Type
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Clinical Area
14.4.9.2. Market Revenue and Forecast, by Technology Type
14.4.9.3. Market Revenue and Forecast, by Deployment Type
14.4.9.4. Market Revenue and Forecast, by Imaging Modality
14.4.9.5. Market Revenue and Forecast, by Functionality
14.4.9.6. Market Revenue and Forecast, by End User
14.4.9.7. Market Revenue and Forecast, by Product Type
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Clinical Area
14.4.10.2. Market Revenue and Forecast, by Technology Type
14.4.10.3. Market Revenue and Forecast, by Deployment Type
14.4.10.4. Market Revenue and Forecast, by Imaging Modality
14.4.10.5. Market Revenue and Forecast, by Functionality
14.4.10.6. Market Revenue and Forecast, by End User
14.4.10.7. Market Revenue and Forecast, by Product Type
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Clinical Area
14.4.11.2. Market Revenue and Forecast, by Technology Type
14.4.11.3. Market Revenue and Forecast, by Deployment Type
14.4.11.4. Market Revenue and Forecast, by Imaging Modality
14.4.11.5. Market Revenue and Forecast, by Functionality
14.4.11.6. Market Revenue and Forecast, by End User
14.4.11.7. Market Revenue and Forecast, by Product Type
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Clinical Area
14.5.2. Market Revenue and Forecast, by Technology Type
14.5.3. Market Revenue and Forecast, by Deployment Type
14.5.4. Market Revenue and Forecast, by Imaging Modality
14.5.5. Market Revenue and Forecast, by Functionality
14.5.6. Market Revenue and Forecast, by End User
14.5.7. Market Revenue and Forecast, by Product Type
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Clinical Area
14.5.8.2. Market Revenue and Forecast, by Technology Type
14.5.8.3. Market Revenue and Forecast, by Deployment Type
14.5.8.4. Market Revenue and Forecast, by Imaging Modality
14.5.8.5. Market Revenue and Forecast, by Functionality
14.5.8.6. Market Revenue and Forecast, by End User
14.5.8.7. Market Revenue and Forecast, by Product Type
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Clinical Area
14.5.9.2. Market Revenue and Forecast, by Technology Type
14.5.9.3. Market Revenue and Forecast, by Deployment Type
14.5.9.4. Market Revenue and Forecast, by Imaging Modality
14.5.9.5. Market Revenue and Forecast, by Functionality
14.5.9.6. Market Revenue and Forecast, by End User
14.5.9.7. Market Revenue and Forecast, by Product Type
15.1. Agfa-Gevaert Group
15.1.1. Company Overview
15.1.2. Technology Type Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Ada Health
15.2.1. Company Overview
15.2.2. Technology Type Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Enlitic Inc
15.3.1. Company Overview
15.3.2. Technology Type Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. CELLMATIQ GMBH
15.4.1. Company Overview
15.4.2. Technology Type Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. GENERAL ELECTRIC COMPANY
15.5.1. Company Overview
15.5.2. Technology Type Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. IBM
15.6.1. Company Overview
15.6.2. Technology Type Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. NVIDIA CORPORATION
15.7.1. Company Overview
15.7.2. Technology Type Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. MICROSOFT
15.8.1. Company Overview
15.8.2. Technology Type Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. KONINKLIJKE PHILIPS N.V.
15.9.1. Company Overview
15.9.2. Technology Type Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. SIEMENS
15.10.1. Company Overview
15.10.2. Technology Type Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
